استمتع بـUnlimited مع Magzter GOLD

استمتع بـUnlimited مع Magzter GOLD

احصل على وصول غير محدود إلى أكثر من 9000 مجلة وصحيفة وقصة مميزة مقابل

$149.99
 
$74.99/سنة

يحاول ذهب - حر

How AI Caught Leukemia In Parbhani

June 09, 2025

|

Mint Mumbai

India's rural and semi-urban healthcare infrastructure is fragmented and stretched thin. At times, compounders play the role of doctors.

- Pankaj Mishra

How AI Caught Leukemia In Parbhani

From the window of Udyati Pathology Lab, the noise of Parbhani is relentless. A chaos of honking scooters, impatient rickshaws and street vendors shouting their daily specials rises from the road below. Just steps away, the railway station adds its own chorus—train announcements crackling through loudspeakers, metal wheels screeching against tracks. The air filled with the small-town urgency of life in motion.

Inside, Dr Chaitanya K. sits in front of a microscope and a half-drunk cup of tea. On the wall, a faded sign reads in hand-painted Marathi: "Accurate diagnosis, unwavering trust."

But here, accuracy has always been a battle fought against exhaustion, distractions and overwhelming demand.

A paediatric blood report arrives on Chaitanya's screen. The numbers seem ordinary: white blood cells normal; haemoglobin slightly low; platelets borderline. Typical monsoon fever, he thinks, almost ready to dismiss it. But experience and the scars of past misdiagnoses have taught him caution.

Instead of signing off, he gently places the slide into an artificial intelligence (AI)-powered scanner he recently bought, against nearly everyone's advice.

Amid the clamour rising from the street, the machine begins examining hundreds of cells, undistracted by the relentless noise below.

Then, a red notification flashes on the screen. Blast cells: 86%.

Chaitanya stares briefly. There's no ambiguity.

"That's leukaemia."

Across town, in a dimly lit paediatric ward at the government hospital, Prasad Pawar, a sugarcane farmer from a village nearby, wipes sweat gently from his son's forehead. The 12-year-old boy lies listless, IV fluids dripping slowly into his arm. For days they had moved from clinic to clinic, first an orthopaedist for back pain, then a paediatrician suspecting dengue. No one said the word "cancer." No one thought it necessary to look deeper.

"He had some pain in his back, so we writer later.

المزيد من القصص من Mint Mumbai

Mint Mumbai

BUDGET TO KEEP FISC STEADY AMID GLOBAL STORM

The Union Budget for FY27 is being formulated against the backdrop of some positive surprises, despite a highly volatile and uncertain global environment.

time to read

3 mins

January 23, 2026

Mint Mumbai

Mint Mumbai

Govt may raise allocation for power distribution reforms

Revamped Distribution Sector Scheme is likely to get ₹18,000 crore in the FY27 budget

time to read

2 mins

January 23, 2026

Mint Mumbai

Pet care startups eye users to compete with FMCG giants

Direct-to-consumer (D2C) pet care brands are leaning on subscription models to lock in customers, betting that repeat purchases can help them counter the scale and distribution advantage of India's largest packaged consumer goods players as the niche segment heats up.

time to read

2 mins

January 23, 2026

Mint Mumbai

IT majors face weak FY26 despite Q3 earnings beats

Four top IT services firms are heading into Q4 with weaker full-year trajectories than last year

time to read

3 mins

January 23, 2026

Mint Mumbai

Here's how to build an education fund in a high-inflation economy

With education inflation running at 10-12% annually, far outpacing CPI, parents must rethink savings strategies

time to read

4 mins

January 23, 2026

Mint Mumbai

Zydus launches cancer biosimilar

Zydus Lifesciences has launched its biosimilar of anticancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the patented version.

time to read

1 min

January 23, 2026

Mint Mumbai

AI accessibility: We need to clearly define what it means

As the world approaches the India AI Summit 2026 , the conversation on AI has evolved beyond algorithmic efficiency to encompass the more significant issues of digital sovereignty and ethics.

time to read

3 mins

January 23, 2026

Mint Mumbai

Retail boosts IPO odds via parent shares

A smart move? Investors are reviving an old strategy by buying parent shares ahead of subsidiary IPOs.

time to read

3 mins

January 23, 2026

Mint Mumbai

Behind Kalyan Jewellers’ stock slump

Kalyan Jewellers has had a rough start to 2026, with the stock sliding around 22% this calendar year, lagging peers.

time to read

3 mins

January 23, 2026

Mint Mumbai

Family-run Duroflex gears up for IPO

After more than six decades as a privately held, family-run business, mattress maker Duroflex believes it is ready for the public markets, top executives of the company told Mint.

time to read

2 mins

January 23, 2026

Listen

Translate

Share

-
+

Change font size